Evidence map›Paper›PMID 30690767›Full record

ArticleBritish journal of clinical pharmacology2019

Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantation.

Benedetta C Sallustio, Benjamin D Noll, Janet K Coller, Jonathan Tuke, Graeme Russ, Andrew A Somogyi

Open access · greenAbstract read
In one paragraph

Article in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Benedetta C SallustioDepartment of Clinical Pharmacology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA, 5011, Australia.ORCID 0000-0002-0186-3073
Benjamin D NollSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
Janet K CollerDiscipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.
Jonathan TukeARC Centre for Excellence for Mathematical and Statistical Frontiers, School of Mathematical Sciences, Adelaide, SA, 5000, Australia.
Graeme RussCentral Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.
Andrew A SomogyiDiscipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.
The University of Adelaide · AUARC Centre of Excellence for Mathematical and Statistical Frontiers · AUBasil Hetzel Institute · AURoyal Adelaide Hospital · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immunosuppressant cyclosporin is a P-glycoprotein (P-gp) substrate whose impaired function has been associated with an increased risk of cyclosporin-induced nephrotoxicity following renal transplantation. This study investigated the relationship between blood and allograft cyclosporin concentration, and the effect of P-gp expression. Fifty biopsy samples were obtained from 39 renal transplant recipients who received cyclosporin as part of maintenance immunosuppression. Blood cyclosporin concentrations (2 hours postdose) were obtained from clinical records, matching allograft cyclosporin concentrations were measured in frozen biopsy tissue by liquid chromatography-tandem mass spectrometry, and allograft P-gp expression was assessed by immunohistochemistry. Blood and allograft cyclosporin concentrations in the 1st month post-transplantation ranged from 505-2005 μg/L and 0.01-16.7 ng/mg tissue, respectively. Dose was the only significant predictor of allograft cyclosporin concentrations (adjusted R

Indexed as

AdolescentAdultAgedAllograftsATP Binding Cassette Transporter, Subfamily BBiopsyCalcineurin InhibitorsCyclosporineDose-Response Relationship, DrugFemaleGraft RejectionHumansKidneyKidney TransplantationMaleMiddle AgedABCB1 protein, humanATP Binding Cassette Transporter, Subfamily BCalcineurin InhibitorsCyclosporineallograft concentrationscyclosporinkidney transplantationP-glycoprotein

Identifiers

PMID30690767
PMCPMC6475688
OpenAlexW2912949938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.